Logo
x

Search

Subscribe Now

 breast cancer

Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer

Accent Therapeutics Receives the US FDA’s IND Approval of ATX-559 for Treating Breast Cancer

  • October 25, 2024
Daiichi Sankyo Reports the sNDA Submission of Enhertu to Treat HER2 Low or Ultralow Metastatic Breast Cancer in Japan

Daiichi Sankyo Reports the sNDA Submission of Enhertu to Treat HER2 Low or Ultralow Metastatic Breast Cancer in Japan

  • October 4, 2024
Key Biosimilars Events of September 2024

Key Biosimilars Events of September 2024

  • October 4, 2024
Organon and Shanghai Henlius Biotech Provides Update on P-III Trial of HLX11 (Biosimilar, Perjeta)

Organon and Shanghai Henlius Biotech Provides Update on P-III Trial of HLX11 (Biosimilar, Perjeta)

  • September 30, 2024
Genentech Reports the Acquisition of Regor's CDK Inhibitors Portfolio Targeting Breast Cancer

Genentech Reports the Acquisition of Regor's CDK Inhibitors Portfolio Targeting Breast Cancer

  • September 30, 2024
AstraZeneca and Daiichi Sankyo Provide Update on the P-III (TROPION-Breast01) Study of Datopotamab Deruxtecan to Treat Breast Cancer

AstraZeneca and Daiichi Sankyo Provide Update on the P-III (TROPION-Breast01) Study of Datopotamab Deruxtecan to Treat Breast Canc...

  • September 23, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.